StockWatch
·
Pharmaceuticals
Regulatory12 Aug 2026, 06:51 pm

Ind-Swift Labs: Monitoring Agency Report for Preferential Issue Proceeds

AI Summary

Ind-Swift Laboratories Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, concerning the utilization of proceeds from its preferential issue. The report, prepared by CARE Ratings Limited, confirms no deviation from the stated objects of the issue. The preferential issue aggregated to Rs. 314.60 crore. The report has been reviewed by the Audit Committee and taken on record by the Board of Directors.

Key Highlights

  • Monitoring Agency Report submitted for preferential issue proceeds.
  • No deviation from the objects of the preferential issue.
  • Preferential issue amount: Rs. 314.60 crore.
  • Report covers utilization for the quarter ended June 30, 2026.
  • Report reviewed by Audit Committee and Board.